Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiology | 63 | 2023 | 1656 | 6.740 |
Why?
|
Heart Valve Prosthesis Implantation | 56 | 2024 | 1553 | 6.130 |
Why?
|
Aortic Valve Stenosis | 40 | 2024 | 2003 | 5.900 |
Why?
|
Mitral Valve Insufficiency | 41 | 2023 | 1400 | 5.580 |
Why?
|
Heart Valve Diseases | 42 | 2022 | 1028 | 3.790 |
Why?
|
Endocarditis, Bacterial | 17 | 2023 | 436 | 2.950 |
Why?
|
Tricuspid Valve Insufficiency | 10 | 2024 | 352 | 2.820 |
Why?
|
Aortic Valve | 36 | 2024 | 1955 | 2.810 |
Why?
|
Heart Valve Prosthesis | 28 | 2024 | 1462 | 2.800 |
Why?
|
Mitral Valve Annuloplasty | 11 | 2021 | 144 | 2.330 |
Why?
|
Endocarditis | 12 | 2023 | 348 | 2.230 |
Why?
|
Mitral Valve | 30 | 2024 | 1464 | 2.170 |
Why?
|
Aortic Valve Insufficiency | 11 | 2023 | 576 | 2.090 |
Why?
|
Coronary Artery Bypass | 26 | 2023 | 2188 | 2.080 |
Why?
|
Societies, Medical | 32 | 2019 | 3901 | 2.050 |
Why?
|
Aortic Aneurysm | 22 | 2023 | 648 | 1.980 |
Why?
|
American Heart Association | 39 | 2023 | 1039 | 1.750 |
Why?
|
Myocardial Reperfusion | 4 | 2012 | 338 | 1.520 |
Why?
|
Certification | 4 | 2015 | 418 | 1.440 |
Why?
|
Advisory Committees | 11 | 2020 | 787 | 1.430 |
Why?
|
Thrombolytic Therapy | 11 | 2016 | 2055 | 1.340 |
Why?
|
Myocardial Infarction | 31 | 2024 | 11458 | 1.280 |
Why?
|
Thoracic Surgery | 11 | 2019 | 722 | 1.250 |
Why?
|
Clinical Competence | 12 | 2020 | 4790 | 1.230 |
Why?
|
Myocardial Ischemia | 18 | 2021 | 2110 | 1.190 |
Why?
|
Coronary Artery Disease | 25 | 2024 | 6403 | 1.160 |
Why?
|
Cardiac Surgical Procedures | 25 | 2024 | 3621 | 1.160 |
Why?
|
Practice Guidelines as Topic | 26 | 2023 | 7390 | 1.140 |
Why?
|
Registries | 28 | 2023 | 8209 | 1.040 |
Why?
|
Humans | 349 | 2024 | 760740 | 0.940 |
Why?
|
Patient Selection | 14 | 2024 | 4237 | 0.930 |
Why?
|
Coronary Angiography | 18 | 2024 | 4470 | 0.930 |
Why?
|
Leadership | 5 | 2018 | 1385 | 0.920 |
Why?
|
Aortic Diseases | 9 | 2023 | 735 | 0.900 |
Why?
|
Evidence-Based Medicine | 18 | 2021 | 3680 | 0.870 |
Why?
|
Mitral Valve Stenosis | 7 | 2020 | 341 | 0.860 |
Why?
|
Antibiotic Prophylaxis | 13 | 2023 | 637 | 0.850 |
Why?
|
Adrenergic beta-Antagonists | 7 | 2016 | 1241 | 0.840 |
Why?
|
Internal Medicine | 3 | 2015 | 1051 | 0.840 |
Why?
|
Disease Management | 14 | 2020 | 2506 | 0.790 |
Why?
|
Research Report | 4 | 2020 | 367 | 0.750 |
Why?
|
Biomedical Research | 5 | 2018 | 3426 | 0.750 |
Why?
|
Heart Murmurs | 2 | 2020 | 92 | 0.710 |
Why?
|
Staphylococcal Infections | 5 | 2017 | 1406 | 0.710 |
Why?
|
Echocardiography | 23 | 2023 | 4987 | 0.700 |
Why?
|
Tricuspid Valve | 5 | 2024 | 409 | 0.680 |
Why?
|
Antihypertensive Agents | 7 | 2023 | 2018 | 0.670 |
Why?
|
Sarcopenia | 1 | 2024 | 370 | 0.650 |
Why?
|
United States | 90 | 2024 | 72292 | 0.650 |
Why?
|
Foramen Ovale, Patent | 3 | 2014 | 208 | 0.630 |
Why?
|
Echocardiography, Transesophageal | 10 | 2020 | 1085 | 0.630 |
Why?
|
Cardiovascular Diseases | 19 | 2020 | 15498 | 0.620 |
Why?
|
Platelet Aggregation Inhibitors | 14 | 2016 | 2746 | 0.620 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2023 | 10203 | 0.600 |
Why?
|
Treatment Outcome | 80 | 2024 | 64572 | 0.600 |
Why?
|
Risk Assessment | 29 | 2020 | 23974 | 0.600 |
Why?
|
Stroke Volume | 15 | 2023 | 5486 | 0.590 |
Why?
|
Physician Executives | 1 | 2018 | 134 | 0.580 |
Why?
|
Education, Medical, Graduate | 7 | 2018 | 2373 | 0.580 |
Why?
|
Severity of Illness Index | 26 | 2024 | 15829 | 0.580 |
Why?
|
Heart Diseases | 10 | 2018 | 2778 | 0.580 |
Why?
|
Angioplasty, Balloon, Coronary | 9 | 2011 | 1723 | 0.570 |
Why?
|
Aortic Aneurysm, Thoracic | 9 | 2016 | 696 | 0.570 |
Why?
|
Pregnancy Complications, Cardiovascular | 7 | 2021 | 512 | 0.550 |
Why?
|
Patient Participation | 2 | 2016 | 1443 | 0.550 |
Why?
|
Pacemaker, Artificial | 6 | 2024 | 805 | 0.540 |
Why?
|
Hematoma | 6 | 2014 | 762 | 0.530 |
Why?
|
Pericarditis, Constrictive | 1 | 2016 | 46 | 0.520 |
Why?
|
Atrial Fibrillation | 10 | 2023 | 5031 | 0.510 |
Why?
|
Physician Self-Referral | 1 | 2015 | 18 | 0.510 |
Why?
|
Clinical Protocols | 8 | 2019 | 1436 | 0.500 |
Why?
|
Hospital Mortality | 15 | 2021 | 5292 | 0.500 |
Why?
|
Fever | 2 | 2020 | 1618 | 0.500 |
Why?
|
Search Engine | 1 | 2016 | 142 | 0.490 |
Why?
|
Aspirin | 10 | 2020 | 3127 | 0.490 |
Why?
|
Saphenous Vein | 3 | 2022 | 516 | 0.490 |
Why?
|
Cardiac Tamponade | 2 | 2016 | 173 | 0.490 |
Why?
|
Committee Membership | 1 | 2014 | 17 | 0.490 |
Why?
|
Consensus | 12 | 2021 | 3117 | 0.480 |
Why?
|
Calcinosis | 1 | 2023 | 1469 | 0.480 |
Why?
|
Cardiovascular System | 2 | 2023 | 834 | 0.480 |
Why?
|
Electrocardiography | 21 | 2017 | 6346 | 0.470 |
Why?
|
Rehabilitation | 1 | 2015 | 130 | 0.470 |
Why?
|
Heart Failure | 24 | 2023 | 11670 | 0.470 |
Why?
|
Patient Education as Topic | 4 | 2016 | 2315 | 0.470 |
Why?
|
Hypertension | 12 | 2023 | 8532 | 0.460 |
Why?
|
Heart Valves | 4 | 2021 | 284 | 0.460 |
Why?
|
Vancomycin | 1 | 2017 | 503 | 0.450 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2020 | 2118 | 0.450 |
Why?
|
Bioprosthesis | 4 | 2024 | 591 | 0.450 |
Why?
|
Benchmarking | 2 | 2020 | 1045 | 0.450 |
Why?
|
Pericardial Effusion | 1 | 2016 | 247 | 0.440 |
Why?
|
Diagnostic Techniques, Cardiovascular | 6 | 2015 | 148 | 0.440 |
Why?
|
Cardiac Valve Annuloplasty | 4 | 2024 | 51 | 0.430 |
Why?
|
Aorta | 6 | 2023 | 2041 | 0.410 |
Why?
|
Medicare | 8 | 2022 | 6774 | 0.410 |
Why?
|
Ownership | 1 | 2015 | 339 | 0.410 |
Why?
|
Ulcer | 1 | 2014 | 203 | 0.410 |
Why?
|
Acute Disease | 23 | 2023 | 7236 | 0.410 |
Why?
|
Cardiovascular Agents | 3 | 2014 | 840 | 0.400 |
Why?
|
Risk Factors | 59 | 2024 | 74128 | 0.400 |
Why?
|
Aged | 98 | 2024 | 169092 | 0.400 |
Why?
|
Patient-Centered Care | 2 | 2020 | 1419 | 0.400 |
Why?
|
Malnutrition | 1 | 2018 | 622 | 0.400 |
Why?
|
Male | 132 | 2024 | 360402 | 0.400 |
Why?
|
Sarcoidosis | 1 | 2017 | 520 | 0.400 |
Why?
|
Patient Care Team | 5 | 2019 | 2515 | 0.390 |
Why?
|
Ticlopidine | 3 | 2011 | 730 | 0.390 |
Why?
|
Medication Therapy Management | 4 | 2012 | 130 | 0.390 |
Why?
|
Stroke | 14 | 2023 | 9715 | 0.380 |
Why?
|
Abscess | 1 | 2015 | 606 | 0.380 |
Why?
|
Drug-Eluting Stents | 3 | 2021 | 681 | 0.380 |
Why?
|
Ventricular Remodeling | 8 | 2022 | 1265 | 0.380 |
Why?
|
Postoperative Complications | 28 | 2024 | 15609 | 0.370 |
Why?
|
Exercise Test | 10 | 2017 | 2127 | 0.370 |
Why?
|
Vasodilator Agents | 3 | 2014 | 973 | 0.360 |
Why?
|
Thoracic Surgical Procedures | 3 | 2013 | 350 | 0.360 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2014 | 385 | 0.360 |
Why?
|
Predictive Value of Tests | 15 | 2023 | 15250 | 0.360 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 697 | 0.360 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2016 | 607 | 0.350 |
Why?
|
Research Support as Topic | 1 | 2014 | 697 | 0.350 |
Why?
|
Cardiac Imaging Techniques | 4 | 2017 | 266 | 0.350 |
Why?
|
Drugs, Investigational | 1 | 2012 | 212 | 0.340 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 729 | 0.340 |
Why?
|
Referral and Consultation | 3 | 2021 | 3599 | 0.340 |
Why?
|
Female | 130 | 2024 | 392203 | 0.340 |
Why?
|
Physicians | 3 | 2018 | 4583 | 0.340 |
Why?
|
Forecasting | 7 | 2019 | 2924 | 0.340 |
Why?
|
Aorta, Thoracic | 7 | 2021 | 1096 | 0.340 |
Why?
|
Puerperal Disorders | 2 | 2021 | 300 | 0.330 |
Why?
|
Preventive Health Services | 1 | 2014 | 566 | 0.330 |
Why?
|
Patient Readmission | 6 | 2020 | 3269 | 0.330 |
Why?
|
Clinical Trials as Topic | 11 | 2024 | 7995 | 0.330 |
Why?
|
Education, Medical, Continuing | 5 | 2015 | 825 | 0.320 |
Why?
|
Thoracic Diseases | 1 | 2010 | 99 | 0.320 |
Why?
|
Myocardial Revascularization | 3 | 2024 | 790 | 0.320 |
Why?
|
Quality Indicators, Health Care | 6 | 2020 | 1790 | 0.310 |
Why?
|
Heart Defects, Congenital | 5 | 2019 | 4671 | 0.300 |
Why?
|
Physician's Role | 1 | 2015 | 917 | 0.300 |
Why?
|
Ventricular Function, Left | 12 | 2023 | 3873 | 0.290 |
Why?
|
Acute Coronary Syndrome | 3 | 2023 | 2190 | 0.290 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2009 | 258 | 0.290 |
Why?
|
Stents | 9 | 2014 | 3177 | 0.280 |
Why?
|
Quality of Life | 13 | 2022 | 13359 | 0.280 |
Why?
|
Anticoagulants | 12 | 2019 | 4785 | 0.280 |
Why?
|
Cardiomyopathy, Hypertrophic | 8 | 2021 | 1310 | 0.280 |
Why?
|
Cardiomyopathies | 2 | 2017 | 1948 | 0.280 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2022 | 324 | 0.280 |
Why?
|
Hospital Costs | 5 | 2020 | 947 | 0.280 |
Why?
|
Mediastinal Neoplasms | 1 | 2009 | 401 | 0.270 |
Why?
|
Cause of Death | 4 | 2019 | 3683 | 0.270 |
Why?
|
Tomography, X-Ray Computed | 12 | 2015 | 20556 | 0.270 |
Why?
|
Reoperation | 6 | 2024 | 4300 | 0.270 |
Why?
|
Delirium | 5 | 2023 | 1667 | 0.260 |
Why?
|
Guideline Adherence | 1 | 2016 | 2218 | 0.260 |
Why?
|
Coronary Aneurysm | 1 | 2008 | 232 | 0.260 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 587 | 0.250 |
Why?
|
Research Design | 4 | 2018 | 6174 | 0.240 |
Why?
|
Amiodarone | 2 | 2016 | 217 | 0.240 |
Why?
|
Middle Aged | 85 | 2024 | 220603 | 0.230 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2252 | 0.230 |
Why?
|
Denervation | 2 | 2023 | 265 | 0.230 |
Why?
|
Emergency Medical Services | 5 | 2012 | 1921 | 0.230 |
Why?
|
Databases, Factual | 4 | 2020 | 7963 | 0.220 |
Why?
|
Streptococcal Infections | 4 | 2015 | 617 | 0.220 |
Why?
|
Systole | 4 | 2021 | 935 | 0.220 |
Why?
|
Perioperative Care | 4 | 2016 | 1037 | 0.220 |
Why?
|
Dental Calculus | 1 | 2023 | 12 | 0.220 |
Why?
|
Time Factors | 29 | 2023 | 39908 | 0.220 |
Why?
|
Periodicals as Topic | 1 | 2014 | 1463 | 0.210 |
Why?
|
Diabetic Angiopathies | 2 | 2005 | 803 | 0.210 |
Why?
|
Rheumatic Heart Disease | 3 | 2015 | 163 | 0.210 |
Why?
|
Heart Ventricles | 10 | 2022 | 3796 | 0.200 |
Why?
|
Critical Care | 2 | 2015 | 2691 | 0.200 |
Why?
|
Health Promotion | 1 | 2014 | 2206 | 0.200 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7403 | 0.200 |
Why?
|
Cooperative Behavior | 3 | 2017 | 1505 | 0.200 |
Why?
|
Oral Hygiene | 1 | 2023 | 132 | 0.200 |
Why?
|
Graft Occlusion, Vascular | 2 | 2022 | 537 | 0.200 |
Why?
|
Prosthesis Failure | 4 | 2024 | 1204 | 0.200 |
Why?
|
Organizational Innovation | 2 | 2016 | 537 | 0.200 |
Why?
|
Vascular Surgical Procedures | 4 | 2016 | 1489 | 0.200 |
Why?
|
Patient Care | 2 | 2020 | 621 | 0.190 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2019 | 499 | 0.190 |
Why?
|
Renal Insufficiency | 2 | 2004 | 808 | 0.190 |
Why?
|
Coronary Disease | 9 | 2014 | 5911 | 0.190 |
Why?
|
Central Nervous System Neoplasms | 1 | 2009 | 915 | 0.190 |
Why?
|
Oral Surgical Procedures | 1 | 2023 | 166 | 0.190 |
Why?
|
Recovery of Function | 5 | 2021 | 2977 | 0.190 |
Why?
|
Coronary Circulation | 3 | 2019 | 1569 | 0.180 |
Why?
|
Myocardial Contraction | 11 | 2005 | 1515 | 0.180 |
Why?
|
Risk | 5 | 2023 | 9603 | 0.180 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3527 | 0.180 |
Why?
|
Catheter Ablation | 3 | 2019 | 2634 | 0.180 |
Why?
|
Coronary Vasospasm | 1 | 2000 | 81 | 0.180 |
Why?
|
Secondary Prevention | 5 | 2016 | 1470 | 0.170 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1405 | 0.170 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2012 | 188 | 0.170 |
Why?
|
Heart | 11 | 2023 | 4403 | 0.170 |
Why?
|
Aged, 80 and over | 19 | 2024 | 58919 | 0.170 |
Why?
|
Concept Formation | 1 | 2020 | 161 | 0.160 |
Why?
|
Natriuretic Peptides | 1 | 2020 | 155 | 0.160 |
Why?
|
Blood Vessel Prosthesis Implantation | 6 | 2018 | 1426 | 0.160 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2022 | 852 | 0.160 |
Why?
|
Angiography | 4 | 2019 | 1595 | 0.160 |
Why?
|
Fish Oils | 2 | 2013 | 483 | 0.160 |
Why?
|
Syncope | 3 | 2017 | 428 | 0.160 |
Why?
|
Interpersonal Relations | 2 | 2018 | 1438 | 0.160 |
Why?
|
Hypothyroidism | 1 | 2023 | 668 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 2 | 2023 | 1642 | 0.150 |
Why?
|
Decision Making | 5 | 2016 | 3919 | 0.150 |
Why?
|
Shock, Cardiogenic | 1 | 2024 | 709 | 0.150 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2018 | 105 | 0.150 |
Why?
|
Internationality | 3 | 2014 | 1000 | 0.150 |
Why?
|
Disease Progression | 6 | 2021 | 13495 | 0.150 |
Why?
|
Isoproterenol | 8 | 1998 | 397 | 0.150 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.150 |
Why?
|
Drug Labeling | 2 | 2010 | 248 | 0.150 |
Why?
|
Thrombosis | 2 | 2014 | 2942 | 0.150 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2016 | 763 | 0.150 |
Why?
|
Coronary Thrombosis | 5 | 2007 | 440 | 0.150 |
Why?
|
Tooth Extraction | 3 | 2023 | 229 | 0.140 |
Why?
|
Quality Assurance, Health Care | 4 | 2019 | 2164 | 0.140 |
Why?
|
Embolic Protection Devices | 1 | 2017 | 42 | 0.140 |
Why?
|
Defibrillators, Implantable | 2 | 2024 | 1483 | 0.140 |
Why?
|
Hospitals | 3 | 2020 | 3879 | 0.140 |
Why?
|
Calcium Channel Blockers | 2 | 2014 | 694 | 0.140 |
Why?
|
Hemodynamics | 10 | 2021 | 4160 | 0.140 |
Why?
|
Oceans and Seas | 1 | 2016 | 47 | 0.140 |
Why?
|
Goals | 2 | 2019 | 708 | 0.130 |
Why?
|
Thrombectomy | 2 | 2019 | 702 | 0.130 |
Why?
|
Vascular Patency | 4 | 2022 | 911 | 0.130 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2022 | 575 | 0.130 |
Why?
|
Multicenter Studies as Topic | 3 | 2019 | 1700 | 0.130 |
Why?
|
Adult | 43 | 2023 | 220995 | 0.130 |
Why?
|
Rheumatic Fever | 2 | 2014 | 73 | 0.130 |
Why?
|
Pulmonary Veins | 2 | 2019 | 716 | 0.130 |
Why?
|
Receptors, Adrenergic, beta | 5 | 1997 | 242 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 1517 | 0.130 |
Why?
|
Fibrinolytic Agents | 3 | 2014 | 2073 | 0.130 |
Why?
|
Aneurysm, Infected | 1 | 2016 | 82 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 4010 | 0.130 |
Why?
|
Bradycardia | 1 | 2017 | 299 | 0.130 |
Why?
|
Atrioventricular Block | 1 | 2017 | 132 | 0.130 |
Why?
|
Heart-Assist Devices | 2 | 2019 | 1288 | 0.130 |
Why?
|
Myocarditis | 2 | 2021 | 788 | 0.130 |
Why?
|
Bundle-Branch Block | 1 | 2017 | 276 | 0.130 |
Why?
|
Mentors | 2 | 2018 | 661 | 0.130 |
Why?
|
Frail Elderly | 2 | 2018 | 765 | 0.130 |
Why?
|
Brain Infarction | 1 | 2017 | 289 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 1068 | 0.120 |
Why?
|
Length of Stay | 9 | 2020 | 6418 | 0.120 |
Why?
|
Shock | 2 | 2016 | 314 | 0.120 |
Why?
|
Diagnosis, Differential | 5 | 2020 | 12966 | 0.120 |
Why?
|
Prosthesis-Related Infections | 3 | 2016 | 487 | 0.120 |
Why?
|
Recurrence | 10 | 2021 | 8426 | 0.120 |
Why?
|
Prognosis | 13 | 2021 | 29601 | 0.120 |
Why?
|
Learning | 3 | 2018 | 1740 | 0.120 |
Why?
|
Adrenergic beta-Agonists | 5 | 1998 | 346 | 0.120 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.120 |
Why?
|
Torsades de Pointes | 1 | 1995 | 78 | 0.120 |
Why?
|
Warfarin | 2 | 2019 | 1477 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2019 | 940 | 0.110 |
Why?
|
Anti-Infective Agents | 2 | 2015 | 983 | 0.110 |
Why?
|
Follow-Up Studies | 18 | 2022 | 39062 | 0.110 |
Why?
|
Coronary Vessel Anomalies | 1 | 2017 | 307 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1040 | 0.110 |
Why?
|
Heart Arrest | 1 | 2024 | 1513 | 0.110 |
Why?
|
Hospitals, Urban | 1 | 1996 | 500 | 0.110 |
Why?
|
Haloperidol | 1 | 1995 | 389 | 0.110 |
Why?
|
Capital Financing | 1 | 2013 | 58 | 0.110 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2016 | 284 | 0.110 |
Why?
|
Quality Improvement | 3 | 2019 | 3801 | 0.110 |
Why?
|
Organizational Policy | 1 | 2016 | 432 | 0.110 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 236 | 0.110 |
Why?
|
Septal Occluder Device | 1 | 2014 | 125 | 0.110 |
Why?
|
Prospective Studies | 17 | 2023 | 54364 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1067 | 0.110 |
Why?
|
Marfan Syndrome | 3 | 2021 | 236 | 0.100 |
Why?
|
Medical Futility | 1 | 2014 | 136 | 0.100 |
Why?
|
Vaccines | 1 | 2021 | 838 | 0.100 |
Why?
|
Cardiopulmonary Bypass | 4 | 2000 | 1092 | 0.100 |
Why?
|
Incidence | 12 | 2023 | 21339 | 0.100 |
Why?
|
Health Planning Guidelines | 1 | 2013 | 151 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.100 |
Why?
|
Diagnosis-Related Groups | 1 | 2014 | 448 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.100 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2012 | 1390 | 0.100 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 2 | 2010 | 244 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2000 | 1496 | 0.100 |
Why?
|
Prostheses and Implants | 2 | 2009 | 1269 | 0.100 |
Why?
|
Decision Trees | 3 | 2014 | 504 | 0.100 |
Why?
|
Cost-Benefit Analysis | 3 | 2019 | 5493 | 0.100 |
Why?
|
Atherosclerosis | 3 | 2023 | 3400 | 0.100 |
Why?
|
History, 20th Century | 2 | 2018 | 2764 | 0.100 |
Why?
|
Blood Vessel Prosthesis | 1 | 2016 | 951 | 0.090 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2014 | 352 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2013 | 318 | 0.090 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 431 | 0.090 |
Why?
|
Tomography, Emission-Computed | 4 | 2003 | 1122 | 0.090 |
Why?
|
Comorbidity | 10 | 2020 | 10507 | 0.090 |
Why?
|
Cohort Studies | 11 | 2023 | 41464 | 0.090 |
Why?
|
Cocaine-Related Disorders | 1 | 2014 | 461 | 0.090 |
Why?
|
Heparin | 4 | 2000 | 1632 | 0.090 |
Why?
|
Pregnancy | 10 | 2023 | 29869 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1302 | 0.090 |
Why?
|
Patient Discharge | 2 | 2022 | 3442 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8652 | 0.090 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 1990 | 432 | 0.090 |
Why?
|
Coronary Stenosis | 1 | 2016 | 794 | 0.090 |
Why?
|
Financing, Government | 1 | 2013 | 472 | 0.090 |
Why?
|
Thromboembolism | 1 | 2016 | 991 | 0.090 |
Why?
|
Aortography | 2 | 2018 | 421 | 0.080 |
Why?
|
Medicaid | 1 | 2023 | 2814 | 0.080 |
Why?
|
Lung Diseases | 2 | 2020 | 1909 | 0.080 |
Why?
|
Radiography | 3 | 2014 | 6961 | 0.080 |
Why?
|
Hyperplasia | 2 | 2022 | 1150 | 0.080 |
Why?
|
Myocardium | 9 | 2019 | 4725 | 0.080 |
Why?
|
Retrospective Studies | 19 | 2024 | 80583 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1182 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2008 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2688 | 0.080 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1457 | 0.080 |
Why?
|
Cocaine | 1 | 2014 | 958 | 0.080 |
Why?
|
Diastole | 3 | 2004 | 781 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2019 | 4325 | 0.080 |
Why?
|
Curriculum | 3 | 2016 | 3739 | 0.080 |
Why?
|
Adenoviridae | 2 | 2005 | 1084 | 0.080 |
Why?
|
Prosthesis Design | 3 | 2022 | 2114 | 0.080 |
Why?
|
Endovascular Procedures | 3 | 2018 | 2182 | 0.080 |
Why?
|
Drug Therapy, Combination | 5 | 2011 | 6305 | 0.080 |
Why?
|
Heart Rate | 3 | 2016 | 4181 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 8 | 2023 | 36401 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2650 | 0.070 |
Why?
|
Faculty, Medical | 1 | 2016 | 1204 | 0.070 |
Why?
|
Decision Support Techniques | 2 | 2014 | 1999 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7044 | 0.070 |
Why?
|
United States Food and Drug Administration | 2 | 2020 | 1661 | 0.070 |
Why?
|
Ventricular Function | 3 | 1999 | 406 | 0.070 |
Why?
|
Canada | 3 | 2019 | 2120 | 0.070 |
Why?
|
Hyperglycemia | 2 | 2016 | 1375 | 0.070 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1056 | 0.070 |
Why?
|
Ultrasonography | 3 | 2014 | 5965 | 0.070 |
Why?
|
Sex Factors | 5 | 2024 | 10549 | 0.070 |
Why?
|
Pregnancy Trimester, Third | 1 | 2009 | 582 | 0.070 |
Why?
|
Blood Pressure | 3 | 2017 | 8473 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2023 | 22153 | 0.070 |
Why?
|
Diabetic Nephropathies | 2 | 2005 | 972 | 0.070 |
Why?
|
Pleural Effusion | 1 | 2009 | 341 | 0.070 |
Why?
|
Postoperative Care | 1 | 2013 | 1467 | 0.070 |
Why?
|
Dilatation, Pathologic | 2 | 2021 | 527 | 0.070 |
Why?
|
Drug Interactions | 1 | 2011 | 1415 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2009 | 1835 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8516 | 0.060 |
Why?
|
Mesenteric Artery, Superior | 1 | 2006 | 96 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2008 | 488 | 0.060 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3705 | 0.060 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2018 | 574 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4058 | 0.060 |
Why?
|
Subclavian Artery | 1 | 2006 | 133 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 3 | 2017 | 2234 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6483 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2011 | 4845 | 0.060 |
Why?
|
Survival Analysis | 7 | 2021 | 10072 | 0.060 |
Why?
|
Pneumonia | 1 | 2017 | 2143 | 0.060 |
Why?
|
Lung | 3 | 2023 | 9999 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 1529 | 0.060 |
Why?
|
Propanolamines | 1 | 2005 | 163 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2013 | 1389 | 0.060 |
Why?
|
Models, Economic | 2 | 2019 | 714 | 0.060 |
Why?
|
Age Factors | 8 | 2021 | 18381 | 0.060 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 1533 | 0.060 |
Why?
|
Nitroprusside | 1 | 2004 | 272 | 0.060 |
Why?
|
Hypotension | 2 | 2014 | 879 | 0.060 |
Why?
|
Heart Septum | 2 | 2004 | 299 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3533 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3851 | 0.060 |
Why?
|
Ultrasonics | 1 | 2005 | 207 | 0.060 |
Why?
|
Platelet Adhesiveness | 1 | 1984 | 154 | 0.060 |
Why?
|
Angioplasty, Balloon | 2 | 1986 | 589 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6473 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2007 | 825 | 0.060 |
Why?
|
Carbazoles | 1 | 2005 | 220 | 0.060 |
Why?
|
Blood Transfusion | 4 | 2013 | 1300 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2756 | 0.050 |
Why?
|
Lipomatosis | 1 | 2004 | 112 | 0.050 |
Why?
|
Survival Rate | 6 | 2015 | 12719 | 0.050 |
Why?
|
Hospitalization | 7 | 2021 | 10708 | 0.050 |
Why?
|
Prosthesis Implantation | 2 | 2020 | 591 | 0.050 |
Why?
|
Logistic Models | 6 | 2019 | 13248 | 0.050 |
Why?
|
Case Management | 1 | 2004 | 272 | 0.050 |
Why?
|
Medication Adherence | 1 | 2014 | 2175 | 0.050 |
Why?
|
Drug Costs | 1 | 2011 | 1183 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9054 | 0.050 |
Why?
|
Infarction | 1 | 2023 | 248 | 0.050 |
Why?
|
Aortic Rupture | 1 | 2005 | 319 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14649 | 0.050 |
Why?
|
Quality-Adjusted Life Years | 2 | 2019 | 1723 | 0.050 |
Why?
|
Dextrans | 1 | 1984 | 573 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2011 | 6807 | 0.050 |
Why?
|
Dentistry | 1 | 2022 | 117 | 0.050 |
Why?
|
Spironolactone | 1 | 2005 | 409 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 5838 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3085 | 0.050 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 967 | 0.050 |
Why?
|
Postoperative Period | 3 | 2016 | 1812 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2011 | 10754 | 0.050 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2003 | 1228 | 0.050 |
Why?
|
Algorithms | 6 | 2019 | 14024 | 0.050 |
Why?
|
Treatment Failure | 2 | 2019 | 2635 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 12143 | 0.050 |
Why?
|
Chronic Disease | 4 | 2015 | 9310 | 0.050 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2021 | 40 | 0.050 |
Why?
|
Radiation Dosage | 1 | 2009 | 1956 | 0.050 |
Why?
|
Sinus of Valsalva | 1 | 2021 | 60 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 2003 | 1972 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2021 | 413 | 0.040 |
Why?
|
Lymphoma | 1 | 2009 | 1899 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3239 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2014 | 2948 | 0.040 |
Why?
|
Chest Pain | 2 | 2004 | 1091 | 0.040 |
Why?
|
Preoperative Care | 1 | 2009 | 2242 | 0.040 |
Why?
|
Gene Transfer Techniques | 1 | 2005 | 1202 | 0.040 |
Why?
|
Pericardiocentesis | 1 | 2020 | 77 | 0.040 |
Why?
|
Tachycardia | 2 | 2014 | 597 | 0.040 |
Why?
|
Bibliometrics | 1 | 2023 | 352 | 0.040 |
Why?
|
Guinea Pigs | 6 | 1998 | 1310 | 0.040 |
Why?
|
Enterobacteriaceae Infections | 1 | 2001 | 188 | 0.040 |
Why?
|
Cardiac Care Facilities | 1 | 2019 | 34 | 0.040 |
Why?
|
Europe | 2 | 2018 | 3415 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12043 | 0.040 |
Why?
|
Calcium-Binding Proteins | 2 | 2005 | 1066 | 0.040 |
Why?
|
Mitral Valve Prolapse | 3 | 2008 | 212 | 0.040 |
Why?
|
Calcium | 10 | 1999 | 5717 | 0.040 |
Why?
|
Odds Ratio | 4 | 2013 | 9644 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1096 | 0.040 |
Why?
|
Creatinine | 1 | 2004 | 1895 | 0.040 |
Why?
|
Heart Atria | 3 | 2019 | 1333 | 0.040 |
Why?
|
Seasons | 1 | 2005 | 1518 | 0.040 |
Why?
|
Epistaxis | 1 | 2019 | 112 | 0.040 |
Why?
|
Device Approval | 1 | 2020 | 163 | 0.040 |
Why?
|
Organ Size | 2 | 2021 | 2252 | 0.040 |
Why?
|
Adolescent | 14 | 2023 | 88247 | 0.040 |
Why?
|
Thallium Radioisotopes | 4 | 1992 | 138 | 0.040 |
Why?
|
Immunization | 1 | 2021 | 1217 | 0.040 |
Why?
|
Telemetry | 1 | 2018 | 199 | 0.040 |
Why?
|
Postnatal Care | 1 | 2019 | 260 | 0.040 |
Why?
|
Angina, Unstable | 1 | 2001 | 888 | 0.030 |
Why?
|
Procainamide | 1 | 1996 | 56 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2023 | 2079 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2008 | 1924 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 1997 | 89 | 0.030 |
Why?
|
Cardiac Output, Low | 2 | 2003 | 191 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 223 | 0.030 |
Why?
|
Cyclic AMP | 2 | 1998 | 1463 | 0.030 |
Why?
|
Acute Kidney Injury | 3 | 2017 | 1923 | 0.030 |
Why?
|
Altruism | 1 | 2018 | 208 | 0.030 |
Why?
|
Medication Errors | 1 | 2002 | 783 | 0.030 |
Why?
|
Linear Models | 2 | 2019 | 5866 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 1990 | 3067 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 314 | 0.030 |
Why?
|
Atrial Flutter | 1 | 2018 | 244 | 0.030 |
Why?
|
Coronary Vessels | 2 | 1986 | 3095 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3575 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2005 | 1667 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2000 | 636 | 0.030 |
Why?
|
Injections | 1 | 2019 | 832 | 0.030 |
Why?
|
Sutures | 1 | 2018 | 282 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 913 | 0.030 |
Why?
|
Double-Blind Method | 4 | 2014 | 12333 | 0.030 |
Why?
|
Young Adult | 5 | 2023 | 59191 | 0.030 |
Why?
|
Echocardiography, Doppler | 2 | 2016 | 893 | 0.030 |
Why?
|
Models, Organizational | 1 | 2019 | 544 | 0.030 |
Why?
|
Prevalence | 3 | 2018 | 15702 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3392 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 551 | 0.030 |
Why?
|
Computer Simulation | 2 | 2019 | 6233 | 0.030 |
Why?
|
Echocardiography, Stress | 1 | 2016 | 134 | 0.030 |
Why?
|
Pain | 1 | 2010 | 5062 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 399 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 590 | 0.030 |
Why?
|
Pyridines | 4 | 2007 | 2875 | 0.030 |
Why?
|
Disopyramide | 1 | 1994 | 16 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1386 | 0.030 |
Why?
|
Hypertension, Renal | 1 | 2015 | 135 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2014 | 2925 | 0.030 |
Why?
|
Alkalosis, Respiratory | 1 | 2014 | 20 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 2001 | 1208 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20077 | 0.030 |
Why?
|
Microcirculation | 1 | 2019 | 1272 | 0.030 |
Why?
|
Death, Sudden | 1 | 2016 | 301 | 0.030 |
Why?
|
Device Removal | 1 | 2019 | 629 | 0.030 |
Why?
|
Reference Values | 3 | 2013 | 4919 | 0.030 |
Why?
|
Hypertension, Renovascular | 1 | 1994 | 115 | 0.030 |
Why?
|
Ischemic Attack, Transient | 2 | 2014 | 874 | 0.030 |
Why?
|
Tachycardia, Supraventricular | 1 | 2016 | 266 | 0.030 |
Why?
|
Spinal Cord Ischemia | 1 | 2014 | 94 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2005 | 2569 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5878 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2015 | 291 | 0.030 |
Why?
|
Electric Countershock | 1 | 2016 | 532 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1995 | 1376 | 0.030 |
Why?
|
Mass Screening | 1 | 2008 | 5425 | 0.030 |
Why?
|
Candidiasis | 1 | 2015 | 365 | 0.030 |
Why?
|
Patient Transfer | 1 | 2019 | 793 | 0.030 |
Why?
|
Italy | 1 | 2014 | 842 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 220 | 0.030 |
Why?
|
Catheterization | 3 | 2008 | 1428 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2047 | 0.020 |
Why?
|
Budgets | 1 | 2013 | 230 | 0.020 |
Why?
|
Prenatal Care | 1 | 2019 | 1140 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1116 | 0.020 |
Why?
|
Health Services Needs and Demand | 2 | 2013 | 1400 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2014 | 407 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2013 | 12448 | 0.020 |
Why?
|
Population Dynamics | 1 | 2013 | 306 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2015 | 633 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2327 | 0.020 |
Why?
|
Databases as Topic | 1 | 2012 | 473 | 0.020 |
Why?
|
Sex Distribution | 2 | 2007 | 2278 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 802 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 2014 | 362 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1635 | 0.020 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 1992 | 223 | 0.020 |
Why?
|
Cardiac Complexes, Premature | 1 | 1990 | 63 | 0.020 |
Why?
|
Platelet Transfusion | 1 | 2013 | 298 | 0.020 |
Why?
|
Foundations | 1 | 2010 | 95 | 0.020 |
Why?
|
Information Services | 1 | 2011 | 236 | 0.020 |
Why?
|
Ventricular Outflow Obstruction | 1 | 1992 | 261 | 0.020 |
Why?
|
Radionuclide Angiography | 3 | 1998 | 22 | 0.020 |
Why?
|
Radionuclide Ventriculography | 3 | 1994 | 40 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2011 | 1624 | 0.020 |
Why?
|
Thapsigargin | 2 | 1999 | 102 | 0.020 |
Why?
|
Dental Prophylaxis | 1 | 2008 | 27 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2014 | 981 | 0.020 |
Why?
|
Calcium-Transporting ATPases | 2 | 1999 | 122 | 0.020 |
Why?
|
Verapamil | 1 | 1989 | 242 | 0.020 |
Why?
|
Urogenital Surgical Procedures | 1 | 2008 | 33 | 0.020 |
Why?
|
Bacteremia | 1 | 2015 | 977 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1110 | 0.020 |
Why?
|
Teaching | 1 | 2016 | 1169 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3410 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
Heart Block | 1 | 1990 | 384 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 1991 | 323 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2013 | 568 | 0.020 |
Why?
|
Hemostasis, Surgical | 2 | 2000 | 126 | 0.020 |
Why?
|
Exercise Therapy | 1 | 2015 | 929 | 0.020 |
Why?
|
Tachycardia, Ventricular | 1 | 1996 | 1261 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2899 | 0.020 |
Why?
|
Administration, Oral | 2 | 2011 | 4010 | 0.020 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2008 | 164 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2008 | 510 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1723 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3567 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2016 | 5109 | 0.020 |
Why?
|
Education, Professional | 1 | 2007 | 52 | 0.020 |
Why?
|
Hormones | 1 | 1991 | 869 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 1048 | 0.020 |
Why?
|
Stimulation, Chemical | 2 | 1997 | 306 | 0.020 |
Why?
|
Patient Preference | 1 | 2014 | 925 | 0.020 |
Why?
|
Exercise | 3 | 2014 | 5886 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2014 | 1411 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12759 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1185 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1988 | 590 | 0.020 |
Why?
|
Antisense Elements (Genetics) | 1 | 2005 | 37 | 0.020 |
Why?
|
Vitamin K | 1 | 2008 | 313 | 0.020 |
Why?
|
Drug Delivery Systems | 2 | 2007 | 2222 | 0.020 |
Why?
|
Emergencies | 2 | 1997 | 1217 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 1990 | 466 | 0.020 |
Why?
|
Chronobiology Phenomena | 1 | 2005 | 29 | 0.020 |
Why?
|
Coated Materials, Biocompatible | 1 | 2007 | 311 | 0.010 |
Why?
|
Cell Size | 2 | 1998 | 624 | 0.010 |
Why?
|
Transfection | 2 | 2005 | 5765 | 0.010 |
Why?
|
Aging | 2 | 1995 | 8700 | 0.010 |
Why?
|
Bleeding Time | 1 | 1984 | 83 | 0.010 |
Why?
|
Blood Glucose | 2 | 2016 | 6390 | 0.010 |
Why?
|
Cells, Cultured | 5 | 1999 | 18937 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4937 | 0.010 |
Why?
|
Immobilization | 1 | 2005 | 229 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 1984 | 397 | 0.010 |
Why?
|
Hemorrhage | 1 | 1995 | 3418 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2008 | 571 | 0.010 |
Why?
|
Boston | 1 | 1996 | 9313 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27100 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1994 | 2642 | 0.010 |
Why?
|
Biological Clocks | 1 | 2005 | 318 | 0.010 |
Why?
|
Membrane Potentials | 2 | 1997 | 1089 | 0.010 |
Why?
|
Animals | 12 | 2008 | 168202 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6561 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1984 | 944 | 0.010 |
Why?
|
Hypertrophy | 1 | 2004 | 560 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3451 | 0.010 |
Why?
|
Molecular Weight | 1 | 1984 | 2185 | 0.010 |
Why?
|
Endothelium | 1 | 1984 | 764 | 0.010 |
Why?
|
Platelet Count | 1 | 1984 | 780 | 0.010 |
Why?
|
Electric Stimulation | 2 | 1998 | 1734 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8835 | 0.010 |
Why?
|
Intraoperative Care | 1 | 2004 | 767 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2003 | 495 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2012 | 3412 | 0.010 |
Why?
|
Dogs | 1 | 1984 | 3837 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3245 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1999 | 455 | 0.010 |
Why?
|
Rats | 3 | 2005 | 23716 | 0.010 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 1999 | 128 | 0.010 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2002 | 494 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2475 | 0.010 |
Why?
|
Endarterectomy, Carotid | 1 | 2004 | 554 | 0.010 |
Why?
|
Iatrogenic Disease | 1 | 2002 | 538 | 0.010 |
Why?
|
Age Distribution | 1 | 2004 | 2872 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1999 | 574 | 0.010 |
Why?
|
Sarcomeres | 2 | 1992 | 369 | 0.010 |
Why?
|
Cardiotonic Agents | 2 | 1992 | 539 | 0.010 |
Why?
|
Thionucleotides | 1 | 1998 | 107 | 0.010 |
Why?
|
Program Development | 1 | 2004 | 1293 | 0.010 |
Why?
|
International Cooperation | 1 | 2004 | 1422 | 0.010 |
Why?
|
Antithrombin III | 1 | 1998 | 128 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 2004 | 877 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2358 | 0.010 |
Why?
|
Prothrombin | 1 | 1998 | 190 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 1997 | 154 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 1997 | 176 | 0.010 |
Why?
|
Syndrome | 1 | 2003 | 3268 | 0.010 |
Why?
|
History, 21st Century | 1 | 2003 | 1566 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 1999 | 836 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1997 | 422 | 0.010 |
Why?
|
Chest Tubes | 1 | 1996 | 152 | 0.010 |
Why?
|
Secretin | 1 | 1975 | 57 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 485 | 0.010 |
Why?
|
Duodenal Ulcer | 1 | 1975 | 121 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2002 | 1528 | 0.010 |
Why?
|
Norepinephrine | 1 | 1998 | 898 | 0.010 |
Why?
|
Ion Channel Gating | 1 | 1997 | 429 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 1998 | 624 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 1997 | 925 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1998 | 915 | 0.010 |
Why?
|
Cell Separation | 2 | 1990 | 1718 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2006 | 2149 | 0.010 |
Why?
|
Potassium Channels | 1 | 1997 | 537 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 8165 | 0.010 |
Why?
|
Rabbits | 2 | 1991 | 4770 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 1999 | 2063 | 0.010 |
Why?
|
Nausea | 1 | 1996 | 679 | 0.010 |
Why?
|
Surface Properties | 1 | 1996 | 1162 | 0.010 |
Why?
|
Glucagon | 1 | 1975 | 531 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2002 | 1669 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1996 | 962 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 1975 | 1178 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 3730 | 0.010 |
Why?
|
Child | 4 | 1995 | 80089 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 1996 | 2630 | 0.010 |
Why?
|
Drainage | 1 | 1996 | 1156 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1997 | 1493 | 0.010 |
Why?
|
Action Potentials | 1 | 1997 | 1825 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 1996 | 1161 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1985 | 4416 | 0.000 |
Why?
|
Tissue Plasminogen Activator | 1 | 1994 | 1163 | 0.000 |
Why?
|
Ventricular Function, Right | 1 | 1992 | 617 | 0.000 |
Why?
|
Diuretics | 1 | 1990 | 611 | 0.000 |
Why?
|
Sheep | 1 | 1990 | 1436 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1994 | 2639 | 0.000 |
Why?
|
Gene Expression | 1 | 1999 | 7569 | 0.000 |
Why?
|
Thallium | 1 | 1986 | 100 | 0.000 |
Why?
|
Psychotropic Drugs | 1 | 1992 | 888 | 0.000 |
Why?
|
Indoles | 1 | 1994 | 1830 | 0.000 |
Why?
|
Species Specificity | 1 | 1990 | 2410 | 0.000 |
Why?
|
Heart Function Tests | 1 | 1986 | 318 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1994 | 2894 | 0.000 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1991 | 831 | 0.000 |
Why?
|
Doxorubicin | 1 | 1991 | 2224 | 0.000 |
Why?
|
Biopsy | 1 | 1996 | 6763 | 0.000 |
Why?
|
Glucose | 1 | 1975 | 4345 | 0.000 |
Why?
|
Body Weight | 1 | 1994 | 4615 | 0.000 |
Why?
|
Physical Exertion | 1 | 1986 | 668 | 0.000 |
Why?
|
Perfusion | 1 | 1986 | 1373 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2002 | 26065 | 0.000 |
Why?
|
Vagotomy | 1 | 1975 | 83 | 0.000 |
Why?
|
Pyloric Antrum | 1 | 1975 | 66 | 0.000 |
Why?
|
Child, Preschool | 1 | 1995 | 42193 | 0.000 |
Why?
|
Intensive Care Units | 1 | 1985 | 3743 | 0.000 |
Why?
|
Gastrectomy | 1 | 1975 | 671 | 0.000 |
Why?
|
Antigens | 1 | 1975 | 1441 | 0.000 |
Why?
|
Mice | 1 | 1990 | 81368 | 0.000 |
Why?
|
Insulin | 1 | 1975 | 6593 | 0.000 |
Why?
|